Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty
Ultrasound-Guided Lumbal Erector Spinae Plane Block on Postoperative Pain Management After Total Hip Arthroplasty
1 other identifier
interventional
60
1 country
1
Brief Summary
The Erector Spinae Plane (ESP) block or spinal erector block was first described in September 2016 by a Canadian team. It's a block that was initially used for the treatment of chronic thoracic neuropathic pain. The ESP block is one of the inter-fascicular blocks and it's an easy-to-perform technique.In the literature, it has been reported that Lumbar ESPB provides effective analgesia after a hip surgery. The purpose of this prospective randomized study was to compare the analgesic effects of the ultrasound-guided lumbar Erector Spinae Plane block on postoperative pain management versus the multimodal analgesia after total hip arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2025
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 7, 2026
November 21, 2025
May 1, 2025
8 months
May 1, 2025
November 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
morphine consumption
total morphine dose
Day 1
Secondary Outcomes (6)
pain scores
Hour 2, Hour 4, Hour 6, Hour 12, Hour 18, Hour 24 and on Day 2 and Day 7.
intraoperative opioid consumption
end of surgery
pain on sitting position
Day 1
QR 9 score
Day 2
ROM
Day 1
- +1 more secondary outcomes
Study Arms (2)
hip arthroplasty with nerve block
ACTIVE COMPARATORLumbar ESP block performed after anesthesia induction. A low-frequency ultrasound probe will be placed longitudinally 2-3 cm lateral to the L4 transverse process. Erector spinae muscle will be visualized on the hyperechoic transverse process. The block needle (100 mm, 22G) will be inserted cranio-caudal direction and following confirmation of the correct position of the needle, between the erectorspinae muscle and the transverse process,30 ml of local anesthetic (0.25% bupivacaine/0.2% ropivacaine) will be administered for the block
hip arthroplasty with intravenous pain killers
PLACEBO COMPARATORintravenous pain killers
Interventions
Lumbar ESP block performed after anesthesia induction. A low-frequency ultrasound probe will be placed longitudinally 2-3 cm lateral to the L4 transverse process. Erector spinae muscle will be visualized on the hyperechoic transverse process. The block needle (100 mm, 22G) will be inserted cranio-caudal direction and following confirmation of the correct position of the needle, between the erectorspinae muscle and the transverse process,30 ml of local anesthetic (0.25% bupivacaine/0.2% ropivacaine) will be administered for the block.
intravenous pain killers
Eligibility Criteria
You may qualify if:
- primary total hip arthroplasty with lateral approach and under general anesthesia .
You may not qualify if:
- Contraindication or refusal to regional anesthesia
- Contraindication to non-steroidal anti-inflammatory (NSAID's)
- Allergy to opioids
- Allergy to paracetamol
- Creatinine clearance \< 30ml/min
- Weight\<50 kg or \>100kg
- Psychiatric disorders and difficulty of communication
- Lower limb neurological deficit
- Patients undergoing bilateral or revision total hip replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kassab Orthopedic Institute
Manouba, 2010, Tunisia
Central Study Contacts
KAABACHI OLFA
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
May 1, 2025
First Posted
November 21, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 7, 2026
Last Updated
November 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share